盟科药业10月10日获融资买入2021.13万元，融资余额8506.13万元

Group 1 - On October 10, Mengke Pharmaceutical experienced a decline of 6.45% with a trading volume of 361 million yuan [1] - The financing data on the same day showed a financing purchase amount of 20.21 million yuan and a financing repayment of 20.51 million yuan, resulting in a net financing outflow of 300,500 yuan [1] - As of October 10, the total balance of margin trading for Mengke Pharmaceutical was 85.06 million yuan, which accounts for 1.89% of its market capitalization and is above the 90th percentile level over the past year [1] Group 2 - As of June 30, the number of shareholders for Mengke Pharmaceutical reached 14,400, an increase of 14.23% compared to the previous period [2] - The average circulating shares per person decreased by 12.45% to 25,342 shares [2] - For the first half of 2025, Mengke Pharmaceutical reported a revenue of 66.97 million yuan, representing a year-on-year growth of 10.26%, while the net profit attributable to shareholders was -139 million yuan, showing a year-on-year increase of 31.11% [2]